Prof Alan Trounson has not resigned from the National Stem Cell Centre, contrary to a report in today's The Australian newspaper. [ + ]

Walter and Eliza Hall Institute cancer researcher Dr David Vaux has been awarded the 2003 Victoria Prize for his pioneering work on the how, when and why of cell death. [ + ]

Microscopy company Iatia has received a 'please explain' from the Australian Stock Exchange after its fourth quarter results showed the company had a net negative operating cash flow for the quarter of AUD$671,000 and $296,000 cash remaining. [ + ]

Shares in Melbourne-based Prana Biotechnology Ltd (ASX:PBT, NASDAQ:PRAN) surged 18 per cent today on news that the company had selected a new, more potent lead compound as a potential preventative therapy and treatment for Alzheimer's disease and related neurodegenerative disorders. [ + ]

CSIRO has beefed up its board with two new non-executive members, one of whom -- Brian Keane -- is a former CEO of insurance giant AAMI. The other is Prof Alan Robson, vice-chancellor elect of the University of Western Australia. [ + ]

New Zealand biotech Virionyx has hit a rich vein with a development deal for a frontline therapy suitable for a range of high-level infections such as AIDS, SARS, West Nile virus and dengue fever -- plus bioterrorism threats. [ + ]

Cochlear implant inventor Prof Graeme Clark said today that a US study released this week on the risk of meningitis in children receiving cochlear implants confirmed his findings from many years of research. [ + ]

The NSW government has named a team responsible for reviewing the state's overall medical and health research program. [ + ]

WA based Clinical Cell Culture (C3) has signed a deal with US company Ventrex to manufacture the company’s ReCell autologous skin harvesting device, primarily for the plastic and cosmetic surgery markets. [ + ]

Starpharma has been given the all-clear from the US FDA to begin clinical trials on their dendrimer-based microcidal gel for prevention of HIV infection. [ + ]

Adelaide-based company BresaGen only has enough cash to last until December, according to figures released by the company today. [ + ]

ASX-listed Axon Instruments has picked up an R&D 100 award for its OpusExpress 6000A electrophysiology workstation. [ + ]

The Swiss-based Serono Foundation has awarded a US$90,000 postgraduate fellowship grant to an ex-Melbourne Uni PhD to pursue research into cancer biology. [ + ]

Sydney University PhD candidate Marc Buhler believes he has tracked down the source of an inherited shield against AIDS, an allele of the CCR5 chemokine receptor, which is shared by many people of Jewish and Viking ancestral origins.

A $100 million international project to sequence the bovine genome is being launched following an intensive lobbying effort in which CSIRO played a key role. [ + ]